Alan W Dunton is Director of CorMedix Inc.. Currently has a direct ownership of 40,250 shares of CRMD, which is worth approximately $453,215. The most recent transaction as insider was on Jan 17, 2025, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.3K
163.93% 3M change
163.93% 12M change
Total Value Held $453,215

ALAN W DUNTON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 17 2025
BUY
Grant, award, or other acquisition
-
25,000 Added 38.31%
40,250 Common Stock
Dec 15 2023
BUY
Open market or private purchase
$9,900 $3.3 p/Share
3,000 Added 16.44%
15,250 Common Stock
Dec 14 2023
BUY
Open market or private purchase
$10,350 $3.45 p/Share
3,000 Added 19.67%
12,250 Common Stock
May 17 2023
BUY
Grant, award, or other acquisition
$12,990 $4.33 p/Share
3,000 Added 24.49%
9,250 Common Stock

Also insider at

OGEN
ORAGENICS INC Healthcare
PTN
PALATIN TECHNOLOGIES INC Healthcare
AWD

Alan W Dunton

Director
Tampa, FL

Track Institutional and Insider Activities on CRMD

Follow CorMedix Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRMD shares.

Notify only if

Insider Trading

Get notified when an Cor Medix Inc. insider buys or sells CRMD shares.

Notify only if

News

Receive news related to CorMedix Inc.

Track Activities on CRMD